Chonbuk National University
Also known as: Chonbuk National Universitiy Hospital | Chonbuk National University Hospital | Chonbuk National University Hospital in Korea | Chonbuk National University Hospital, Korea | Chonbuk National Universtiy Hospital of Korea | Chonbuk university hospital | Chonkbuk national university | Chounbuk National University | Chounbuk National University Hospital | Chungbuk National University Hosipital. | Chungbuk National University Hospital | ChungBuk National Unviersity Hospital. | Department of Clinical Pharmacology, Chungbuk National University Hospital
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2006Last known activity
Jul 3, 2024
Timeline
1940s
- Jan 1, 1947
Chonbuk National University— Founded
Drugs by trial phase (185 distinct, 197 trials)
Phase 4 (37 own, 0 via acquisition)
Phase 3 (45 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (62 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Disease
- Anemia
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Atrial Fibrillation
- Biliary Tract Neoplasms
- Bone Diseases, Metabolic
- Cardiovascular Diseases
- Central Nervous System Diseases
- Constipation
- Coronary Artery Disease
- Depression
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Dwarfism
- Dyslipidemias
- Enuresis
- Erectile Dysfunction
- Esophagitis
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatigue Syndrome, Chronic
- Gastritis
- Gastrointestinal Hemorrhage
- Glomerulonephritis
- Glomerulonephritis, IGA
- Gonadal Dysgenesis
- Head and Neck Neoplasms
- Helicobacter Infections
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Infarction
- Infections
- Influenza, Human
- Kidney Diseases
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lower Urinary Tract Symptoms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Malnutrition
- Mental Disorders
- Metabolic Syndrome
- Myelodysplastic Syndromes
- Myocardial Infarction
- Nervous System Diseases
- Neuralgia
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Overweight
- Pancreatic Neoplasms
- Pneumonia
- Prediabetic State
- Premature Birth
- Premature Ejaculation
- Prostatic Hyperplasia
- Psychotic Disorders
- Pulmonary Disease, Chronic Obstructive
- Schizophrenia
- Small Cell Lung Carcinoma
- Spondylitis
- Spondylitis, Ankylosing
- ST Elevation Myocardial Infarction
- Stomach Neoplasms
- Stroke
- Syndrome
- Turner Syndrome
- Ventricular Remodeling
- Wounds and Injuries
Recent trials (50)
- NCT06393881OfficialPhase 1Jul 3, 2024
- NCT06431399OfficialPhase 1Apr 23, 2024
- NCT06618079OfficialPhase 1Apr 20, 2024
- NCT06725992OfficialPhase 1Jan 30, 2024
- NCT06395155OfficialPhase 1Oct 26, 2023
- NCT06141577Overall official - principal investigatorPhase 1Oct 8, 2023
- NCT05952219Overall official - principal investigatorPhase 1Jun 2, 2023
- NCT05797922Overall official - principal investigatorPhase 1Mar 9, 2023
- NCT05729074OfficialPhase 1Feb 13, 2023
- NCT05381194CollaboratorPhase 4Dec 13, 2022
- NCT05523947OfficialPhase 1/Phase 2Aug 26, 2022
- NCT05347576Overall official - principal investigatorPhase 1Apr 21, 2022
- NCT05994547Reponsible party - principal investigatorPhase 4Apr 14, 2022
- NCT05994547Lead sponsorPhase 4Apr 14, 2022
- NCT05770674CollaboratorN/AApr 1, 2022
Details
- Founded
- Jeonju, KR Jan 1, 1947
- Last known activity
- Jul 3, 2024